Publication date: Jul 20, 2023
Primary focus of the research was to determine the incidence of type 1 diabetes mellitus in the period from 2017 to 2022, and whether COVID-19 had an impact on the increase in the number of newly diagnosed children with diabetes type 1 under the age of 15 in the Republic of Srpska (Bosnia and Herzegovina). In the period 2001-2016 the incidence of type 1 diabetes mellitus was 11/100,000, with an annual increasing rate of 14. 2%. Available data from pediatric endocrinology clinics, in the Republic of Srpska, on the number of newly diagnosed patients with diabetes mellitus in the period from January 1, 2017 until December 31, 2022 were used. A retrospective analysis was performed, and the capture-recapture method was used for the final assessment, and the obtained result corresponds to about 99% of the population. The total number of children in the group of 0-14 years of age diagnosed with type 1 diabetes mellitus in this period was 183, of which 96 (52. 46%) were boys, and 87 (47. 54%) were girls. The average age at which diabetes mellitus was diagnosed was 8. 3 +/- 3. 9 years. Average incidence of diabetes in the period 2017-2022 was 19/100,000 (95% CI 13. 1-25. 0). The highest incidence was 28. 7/100,000 in 2020, the first year of the global COVID-19 pandemic. Out of a total of 183 newly diagnosed cases in the period 2017-2022, 73 (39. 9%) were diagnosed with ketoacidosis upon admission. The largest number of newly diagnosed children was recorded in the group of children aged 10-14 years. In the last 6 years, there has been a significant increase in the incidence of type 1 diabetes mellitus in children under the age of 15. With an incidence of 19. 4/100,000 in the Republic of Srpska, we entered the group of countries with high-risk for diabetes. Further steps must focus on the education of the entire society in order to recognize the symptoms of the disease in time and prevent the occurrence of ketoacidosis, which could significantly reduce the burden on health systems, especially in times of global pandemics, such as the COVID-19 pandemic.
Open Access PDF
| Concepts | Keywords |
|---|---|
| Clinics | children |
| Diabetes | COVID-19 |
| Girls | incidence |
| ketoacidosis | |
| type 1 diabetes mellitus |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | type 1 diabetes |
| disease | MESH | ketoacidosis |
| disease | MESH | COVID-19 |
| disease | MESH | diabetes mellitus |
| disease | VO | population |
| disease | VO | time |
| drug | DRUGBANK | Coenzyme M |
| pathway | REACTOME | Reproduction |
| disease | MESH | lifestyle |
| disease | MESH | metabolic diseases |
| disease | IDO | country |
| disease | MESH | infection |
| disease | VO | organization |
| drug | DRUGBANK | Angiotensin II |
| disease | VO | Viruses |
| disease | MESH | virus infection |
| disease | MESH | hypokalemia |
| disease | VO | Canada |
| disease | MESH | diabetic ketoacidosis |
| disease | MESH | death |
| disease | VO | frequency |
| disease | IDO | blood |
| disease | MESH | hyperglycemia |
| disease | IDO | assay |
| disease | VO | protocol |
| disease | MESH | weight gain |
| disease | VO | Apa |
| drug | DRUGBANK | Guanosine |
| drug | DRUGBANK | Tolbutamide |
| disease | MESH | respiratory infections |
| disease | MESH | autoimmunity |